Stay updated on Pembrolizumab Combo in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page
- Check6 days agoChange DetectedThe revision label in the page history changes from v3.6.5 to v3.6.6, indicating a new platform release in the history view.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedFooter now shows Revision: v3.6.5, replacing Revision: v3.6.4. This reflects a new site release.SummaryDifference0.0%

- Check42 days agoChange DetectedA new revision (v3.6.4) was posted on 2026-07-24, adding updates to the Study Status and Contacts/Locations sections of the record history. The previous revision (v3.6.3) from 2026-06-05 was superseded.SummaryDifference0.2%

- Check63 days agoChange DetectedThe Record History page now shows the latest revision as v3.6.3, replacing v3.6.2. This change represents a metadata-level update reflecting the page's rendering version.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page shows a new site revision, updating the footer from v3.6.0 to v3.6.2. This indicates a software version update rather than modification of study data.SummaryDifference0.0%

- Check85 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' signaling that recruitment has closed. The revision history shows a new revision tag, v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.